Published on in Vol 11 (2024)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/54117, first published
.

Journals
- Butruille J, Cirnat N, Alaoui M, Saracco J, Cousein E, Chaniaud N. Pharmaceutical Analysis of Inpatient Prescriptions: Systematic Observation of Hospital Pharmacists’ Practices in the Early User-Centered Design Phase. JMIR Human Factors 2025;12:e65959 View
- Turyahabwe S, Ramachandra S, Quraishi S, Fasih I, Quraishi H, Peddapalegani P, Ahmad A, Omara T. A community based, bottom-up, multi-pronged, technology integrated approach to enhance tuberculosis related awareness and treatment adherence in Uganda: The ACTS model. PLOS ONE 2025;20(2):e0318174 View
- Madden N, Tadesse A, Leung C, Gonçalves Tasca B, Alacapa J, Deyanova N, Ndlovu N, Mokone N, Onjare B, Mganga A, van Kalmthout K, Jerene D, Fielding K. Process Evaluation of Pragmatic Cluster-Randomized Trials of Digital Adherence Technologies for Tuberculosis Treatment Support: A Mixed-Method Study in Five Countries. Tropical Medicine and Infectious Disease 2025;10(3):68 View
- Jerene D, van Kalmthout K, Levy J, Alacapa J, Deyanova N, Dube T, Mganga A, Tasca B, Bogdanov A, Efo E, Gamazina K, Garfin A, Kochanov V, Leung A, Madden N, Maraba N, McQuaid C, Mleoh L, Onjare B, Powers R, Terleiva Y, van Rest J, Gebhard A, Fielding K, Charalambous S. Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials. The Lancet 2025;405(10485):1155 View
- Alacapa J, Tadesse A, Deyanova N, Dube T, Mganga A, Powers R, van Rest J, Madden N, Efo E, Charalambous S, van Kalmthout K, Jerene D, Fielding K. Engagement With Digital Adherence Technologies as Measures of Intervention Fidelity Among Adults With Drug-Susceptible Tuberculosis and Health Care Providers: Descriptive Analysis Using Data From Cluster-Randomized Trials in Five Countries. JMIR Public Health and Surveillance 2025;11:e62881 View
